Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Epicrispr Biotechnologies is a biotechnology enterprise that focuses on epigenetic engineering.
Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.
Nura Bio is a biotechnology company that develops neuroprotective therapies for neurological disorders.
Bionyra Pharma is a clinical-stage biopharmaceutical startup developing next-generation biologics for severe immune-mediated inflammation.
Memento Medicines is a biotech developing bispecific antibody therapies for eye diseases.
The AI Platform for Pharma Commercialization
Click Therapeutics develops and commercializes software as prescription medical treatments designed to address unmet healthcare needs.
QuantX Biosciences is a biotechnology company that specializes in computational drug discovery and small-molecule therapeutic products.
Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.
Lifordi Immunotherapeutics is a biotech company that provides antibody-drug conjugates for autoimmune and inflammatory disorders.
T-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge.
Zag Bio is a biotechnology company that designs thymus-targeting bifunctional antibody medicines to treat and prevent autoimmune diseases.
ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.
Character Bio is a platform that merges genomics with clinical data and AI technology, focusing on patients affected by AMD.
Eligobiotics provides a new approach to explore, understand, and control bacterial ecosystems both in human and animals.
Granite Bio is a biotechnology business developing novel antibodies to treat inflammatory, autoimmune, and fibrotic disorders.
Glycomine is an early-stage biotech working on replacement therapies for rare diseases.
Attovia Therapeutics is a biologics platform specializing in biotherapeutics for immune-mediated diseases.
Latigo Biotherapeutics is a clinical-stage biotechnology company that develops novel, non-opioid therapies for chronic pain.
Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases.
Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases.
NextPoint Therapeutics is a clinical-stage biotechnology company that develops therapeutics to treat cancer patients.
Sudo Biosciences is a biopharma company that designs and develops medicines that target the tyrosine kinase 2 (TYK2) pseudokinase domain.
I2o Therapeutics is a biotech company that develops safe and effective oral formulations of therapies.
Sanofi Ventures has invested in 69 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Sanofi Ventures's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Pharmaceutical. The firm invests across 15 different industry categories.
Among tracked funding rounds, Q32 Bio received $200.0M in a Post-IPO Equity round. Sanofi Ventures's total known invested capital is $4.2B.
Sanofi Ventures's average investment size is $61.3M across its portfolio of 69 companies.
Recent Sanofi Ventures portfolio additions include Epicrispr Biotechnologies, Q32 Bio, Nura Bio, Bionyra, Memento Medicines. These companies were founded in 2020 or later.